Suvretta Capital Management 13F annual report
Suvretta Capital Management is an investment fund managing more than $2.37 trillion ran by Glenn Shepard. There are currently 99 companies in Mr. Shepard’s portfolio. The largest investments include Biohaven Ltd and Kura Oncology Inc, together worth $370 billion.
$2.37 trillion Assets Under Management (AUM)
As of 8th May 2024, Suvretta Capital Management’s top holding is 4,003,046 shares of Biohaven Ltd currently worth over $219 billion and making up 9.2% of the portfolio value.
Relative to the number of outstanding shares of Biohaven Ltd, Suvretta Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 7,069,627 shares of Kura Oncology Inc worth $151 billion, whose value grew 122.9% in the past six months.
The third-largest holding is Arcellx Inc worth $109 billion and the next is Meta Platforms Inc worth $84.3 billion, with 173,605 shares owned.
Currently, Suvretta Capital Management's portfolio is worth at least $2.37 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Suvretta Capital Management
The Suvretta Capital Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Glenn Shepard serves as the Chief Financial Officer at Suvretta Capital Management.
Recent trades
In the most recent 13F filing, Suvretta Capital Management revealed that it had opened a new position in
Coca-Cola Co and bought 546,500 shares worth $33.4 billion.
This means they effectively own approximately 0.1% of the company.
Coca-Cola Co makes up
100.0%
of the fund's Consumer Staples sector allocation and has decreased its share price by 1.3% in the past year.
The investment fund also strengthened its position in Kura Oncology Inc by buying
123,397 additional shares.
This makes their stake in Kura Oncology Inc total 7,069,627 shares worth $151 billion.
Kura Oncology Inc soared 65.2% in the past year.
On the other hand, there are companies that Suvretta Capital Management is getting rid of from its portfolio.
Suvretta Capital Management closed its position in Las Vegas Sands Corp on 15th May 2024.
It sold the previously owned 738,163 shares for $36.3 billion.
Glenn Shepard also disclosed a decreased stake in Biohaven Ltd by 0.1%.
This leaves the value of the investment at $219 billion and 4,003,046 shares.
One of the largest hedge funds
The two most similar investment funds to Suvretta Capital Management are Parsec Management and Hennessy Advisors Inc. They manage $2.37 trillion and $2.37 trillion respectively.
Glenn Shepard investment strategy
Suvretta Capital Management’s portfolio is diversified across 10 sectors.
Currently, their heaviest sector is Health Care — making up 51.3% of
the total portfolio value.
The fund focuses on investments in the United States as
64.6% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
46% of the total holdings value.
On the other hand, small-cap stocks make up only 4.0% of the portfolio.
The average market cap of the portfolio companies is close to $120 billion.
The complete list of Suvretta Capital Management trades based on 13F SEC filings
These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Biohaven Ltd |
12.46%
4,003,046
|
$218,926,586,000 | 9.23% |
| Kura Oncology Inc |
1.78%
7,069,627
|
$150,795,144,000 | 6.36% |
| Arcellx Inc |
35.86%
1,562,354
|
$108,661,721,000 | 4.58% |
| Meta Platforms Inc |
21.15%
173,605
|
$84,299,116,000 | 3.56% |
| Ultragenyx Pharmaceutical In |
21.14%
1,676,811
|
$78,290,306,000 | 3.30% |
| Arcutis Biotherapeutics Inc |
7.03%
7,877,297
|
$78,064,013,000 | 3.29% |
| EyePoint Pharmaceuticals Inc |
7.22%
3,763,888
|
$77,799,565,000 | 3.28% |
| 89bio Inc |
28.83%
6,298,004
|
$73,308,767,000 | 3.09% |
| Royalty Pharma plc |
42.12%
2,250,361
|
$68,343,464,000 | 2.88% |
| Intra-Cellular Therapies Inc |
17.73%
959,198
|
$66,376,502,000 | 2.80% |
| Amazon.com Inc. |
3.02%
356,962
|
$64,388,806,000 | 2.72% |
| Advanced Micro Devices Inc. |
2.47%
341,699
|
$61,673,253,000 | 2.60% |
| Insmed Inc |
24.64%
2,023,000
|
$54,883,990,000 | 2.32% |
| Cigna Group (The) |
42.41%
137,139
|
$49,807,513,000 | 2.10% |
| KalVista Pharmaceuticals Inc |
56.18%
4,192,005
|
$49,717,179,000 | 2.10% |
| Verizon Communications Inc |
64.53%
1,179,452
|
$49,489,806,000 | 2.09% |
| Argenx Se |
127.00%
121,900
|
$47,994,468,000 | 2.02% |
| Marinus Pharmaceuticals Inc |
4.44%
5,108,520
|
$46,181,021,000 | 1.95% |
| Goldman Sachs Group, Inc. |
0.38%
109,890
|
$45,899,954,000 | 1.94% |
| Taiwan Semiconductor Mfg Ltd |
15.17%
329,352
|
$44,808,340,000 | 1.89% |
| AT&T, Inc. |
96.60%
2,398,619
|
$42,215,694,000 | 1.78% |
| Apollo Global Mgmt Inc |
31.47%
370,636
|
$41,678,018,000 | 1.76% |
| Ferguson Plc New |
3.87%
169,280
|
$36,975,830,000 | 1.56% |
| General Electric Co |
41.76%
207,447
|
$36,413,172,000 | 1.54% |
| Las Vegas Sands Corp |
Closed
738,163
|
$36,325,001,000 | |
| Coca-Cola Co |
Opened
546,500
|
$33,434,870,000 | 1.41% |
| Microsoft Corporation |
51.02%
79,317
|
$33,370,248,000 | 1.41% |
| Sutro Biopharma Inc |
No change
5,778,188
|
$32,646,762,000 | 1.38% |
| Mckesson Corporation |
10.75%
56,639
|
$30,406,647,000 | 1.28% |
| Apple Inc |
Opened
176,680
|
$30,297,086,000 | 1.28% |
| CRH Plc |
Opened
335,580
|
$28,947,131,000 | 1.22% |
| Arrivent Biopharma Inc |
Opened
1,563,709
|
$27,927,843,000 | 1.18% |
| Fulcrum Therapeutics Inc |
48.39%
2,848,486
|
$26,889,708,000 | 1.13% |
| Elevance Health Inc |
5.23%
50,925
|
$26,406,650,000 | 1.11% |
| Oracle Corp. |
38.93%
196,674
|
$24,704,221,000 | 1.04% |
| Chipotle Mexican Grill |
8.50%
7,970
|
$23,166,957,000 | 0.98% |
| Bicycle Therapeutics plc |
No change
914,476
|
$22,770,452,000 | 0.96% |
| Pepgen Inc |
212.56%
1,520,932
|
$22,357,700,000 | 0.94% |
| Boston Scientific Corp. |
56.34%
303,035
|
$20,754,867,000 | 0.88% |
| Fate Therapeutics Inc |
Opened
2,562,852
|
$18,811,334,000 | 0.79% |
| Arcus Biosciences Inc |
No change
957,304
|
$18,073,900,000 | 0.76% |
| Hilton Worldwide Holdings Inc |
28.15%
78,502
|
$16,745,262,000 | 0.71% |
| Salesforce Inc |
Opened
55,050
|
$16,579,959,000 | 0.70% |
| Starbucks Corp. |
Opened
172,951
|
$15,805,992,000 | 0.67% |
| Johnson & Johnson |
No change
90,097
|
$14,252,444,000 | 0.60% |
| Global Pmts Inc |
5.59%
106,094
|
$14,180,524,000 | 0.60% |
| Pinterest Inc |
Opened
395,851
|
$13,724,154,000 | 0.58% |
| Mereo BioPharma Group plc |
50.43%
3,653,494
|
$12,056,530,000 | 0.51% |
| Sanofi |
23.22%
210,701
|
$10,240,069,000 | 0.43% |
| Immatics N.v |
Opened
946,563
|
$9,948,377,000 | 0.42% |
| Terns Pharmaceuticals Inc |
76.64%
1,363,675
|
$8,945,708,000 | 0.38% |
| Agios Pharmaceuticals Inc |
Closed
399,451
|
$8,895,774,000 | |
| Inflarx Nv |
No change
5,733,910
|
$8,830,221,000 | 0.37% |
| Elanco Animal Health Inc |
17.43%
507,200
|
$8,257,216,000 | 0.35% |
| Revance Therapeutics Inc |
Opened
1,600,000
|
$7,872,000,000 | 0.33% |
| AnaptysBio Inc |
Closed
354,872
|
$7,601,358,000 | |
| Unitedhealth Group Inc |
17.94%
15,123
|
$7,481,348,000 | 0.32% |
| Zura Bio Ltd |
No change
2,850,000
|
$7,324,500,000 | 0.31% |
| Ge Healthcare Technologies I |
Opened
75,000
|
$6,818,250,000 | 0.29% |
| Korro Bio Inc |
No change
73,821
|
$6,643,890,000 | 0.28% |
| Sana Biotechnology Inc |
Closed
1,606,056
|
$6,552,708,000 | |
| Kezar Life Sciences Inc |
No change
7,167,591
|
$6,462,300,000 | 0.27% |
| Prokidney Corp |
No change
3,867,847
|
$6,343,269,000 | 0.27% |
| Spyre Therapeutics Inc |
No change
162,395
|
$6,159,642,000 | 0.26% |
| Alnylam Pharmaceuticals Inc |
231.24%
32,660
|
$4,881,037,000 | 0.21% |
| Astrazeneca plc |
Closed
70,490
|
$4,747,502,000 | |
| Thermo Fisher Scientific Inc. |
No change
7,260
|
$4,219,585,000 | 0.18% |
| Danaher Corp. |
No change
16,427
|
$4,102,150,000 | 0.17% |
| Abbott Labs |
No change
33,520
|
$3,809,883,000 | 0.16% |
| Teva Pharmaceutical Inds Ltd |
46.10%
268,100
|
$3,782,891,000 | 0.16% |
| Gilead Sciences, Inc. |
123.35%
50,700
|
$3,713,775,000 | 0.16% |
| Kenvue Inc |
No change
171,596
|
$3,682,450,000 | 0.16% |
| Cencora Inc. |
No change
12,488
|
$3,034,459,000 | 0.13% |
| Tourmaline Bio Inc |
Opened
125,000
|
$2,862,500,000 | 0.12% |
| Mettler-Toledo International, Inc. |
Opened
1,964
|
$2,614,654,000 | 0.11% |
| Incyte Corp. |
Closed
37,600
|
$2,360,904,000 | |
| Natera Inc |
No change
24,600
|
$2,249,916,000 | 0.09% |
| Cogent Biosciences, Inc. |
91.48%
316,000
|
$2,123,520,000 | 0.09% |
| Intuitive Surgical Inc |
69.38%
5,200
|
$2,075,268,000 | 0.09% |
| Avantor, Inc. |
87.84%
71,850
|
$1,837,205,000 | 0.08% |
| IQVIA Holdings Inc |
No change
7,175
|
$1,814,486,000 | 0.08% |
| Merck & Co Inc |
Closed
15,500
|
$1,689,810,000 | |
| Molecular Partners Ag |
No change
400,000
|
$1,680,000,000 | 0.07% |
| Stryker Corp. |
No change
4,360
|
$1,560,313,000 | 0.07% |
| Medtronic Plc |
No change
17,460
|
$1,521,639,000 | 0.06% |
| Galapagos NV |
No change
47,200
|
$1,519,840,000 | 0.06% |
| Pfizer Inc. |
Closed
50,300
|
$1,448,137,000 | |
| CVS Health Corp |
No change
17,170
|
$1,369,479,000 | 0.06% |
| Illumina Inc |
No change
8,730
|
$1,198,804,000 | 0.05% |
| Akili Inc |
No change
3,841,718
|
$1,112,562,000 | 0.05% |
| Waters Corp. |
No change
3,150
|
$1,084,325,000 | 0.05% |
| Benitec Biopharma Inc |
No change
204,220
|
$1,072,155,000 | 0.05% |
| HCA Healthcare Inc |
Opened
3,190
|
$1,063,961,000 | 0.04% |
| Edwards Lifesciences Corp |
Opened
11,100
|
$1,060,716,000 | 0.04% |
| Protagonist Therapeutics Inc |
Opened
30,500
|
$882,365,000 | 0.04% |
| Dexcom Inc |
No change
5,880
|
$815,556,000 | 0.03% |
| Agilent Technologies Inc. |
No change
4,990
|
$726,095,000 | 0.03% |
| Morgan Stanley |
59.19%
7,641
|
$719,477,000 | 0.03% |
| Humana Inc. |
Opened
1,950
|
$676,104,000 | 0.03% |
| Idexx Labs Inc |
Closed
920
|
$510,646,000 | |
| Veralto Corp |
No change
5,475
|
$485,414,000 | 0.02% |
| Resmed Inc. |
Opened
2,390
|
$473,292,000 | 0.02% |
| Ionis Pharmaceuticals Inc |
Opened
10,800
|
$468,180,000 | 0.02% |
| Zimmer Biomet Holdings Inc |
Opened
3,260
|
$430,255,000 | 0.02% |
| Align Technology, Inc. |
Opened
1,100
|
$360,712,000 | 0.02% |
| Steris Plc |
Opened
1,530
|
$343,975,000 | 0.01% |
| Baxter International Inc. |
Opened
7,970
|
$340,638,000 | 0.01% |
| United Therapeutics Corp |
Closed
1,360
|
$299,050,000 | |
| Charles Riv Labs Intl Inc |
No change
1,010
|
$273,660,000 | 0.01% |
| Bio-Techne Corp |
Closed
2,600
|
$200,616,000 | |
| No transactions found | |||
| Showing first 500 out of 110 holdings | |||
Hedge funds similar to Suvretta Capital Management
- Klingenstein Fields & Co L.P.
- Perfromance Wealth Partners
- Hyperion Asset Management Ltd
- Lingotto Investment Management LL.P.
- Cevian Capital Ii Gp Ltd
- Burney Co/
- Parsec Management
- Hennessy Advisors Inc
- Great Valley Advisor Group, Inc
- Frazier Life Sciences Management, L.P.
- Cary Street Partners Investment Advisory
- Kensico Capital Management Corp
- Tiedemann Advisors
- Meiji Yasuda Asset Management Co